XML 18 R6.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Shares
Capital in Excess of Par Value
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021   185,468      
Beginning balance at Dec. 31, 2021 $ 679,508 $ 19 $ 3,516,641 $ (4,157) $ (2,832,995)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Shares issued under equity compensation plans (in shares)   806      
Shares issued under equity compensation plans 188   188    
Stock-based compensation 20,961   20,961    
Comprehensive income (loss) (92,768)     (2,375) (90,393)
Ending balance (in shares) at Mar. 31, 2022   186,274      
Ending balance at Mar. 31, 2022 607,889 $ 19 3,537,790 (6,532) (2,923,388)
Beginning balance (in shares) at Dec. 31, 2021   185,468      
Beginning balance at Dec. 31, 2021 679,508 $ 19 3,516,641 (4,157) (2,832,995)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Comprehensive income (loss) (253,495)        
Ending balance (in shares) at Jun. 30, 2022   187,405      
Ending balance at Jun. 30, 2022 458,732 $ 19 3,549,360 (8,191) (3,082,456)
Beginning balance (in shares) at Mar. 31, 2022   186,274      
Beginning balance at Mar. 31, 2022 607,889 $ 19 3,537,790 (6,532) (2,923,388)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Shares issued under equity compensation plans (in shares)   1,131      
Shares issued under equity compensation plans 467   467    
Stock-based compensation 11,103   11,103    
Comprehensive income (loss) (160,727)     (1,659) (159,068)
Ending balance (in shares) at Jun. 30, 2022   187,405      
Ending balance at Jun. 30, 2022 $ 458,732 $ 19 3,549,360 (8,191) (3,082,456)
Beginning balance (in shares) at Dec. 31, 2022 188,560 188,560      
Beginning balance at Dec. 31, 2022 $ 366,638 $ 19 3,574,719 (6,907) (3,201,193)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Shares issued under equity compensation plans (in shares)   675      
Shares issued under equity compensation plans 0   0    
Stock-based compensation 10,019   10,019    
Comprehensive income (loss) (135,792)     1,226 (137,018)
Ending balance (in shares) at Mar. 31, 2023   189,235      
Ending balance at Mar. 31, 2023 $ 240,865 $ 19 3,584,738 (5,681) (3,338,211)
Beginning balance (in shares) at Dec. 31, 2022 188,560 188,560      
Beginning balance at Dec. 31, 2022 $ 366,638 $ 19 3,574,719 (6,907) (3,201,193)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Comprehensive income (loss) $ (187,683)        
Ending balance (in shares) at Jun. 30, 2023 190,119 190,119      
Ending balance at Jun. 30, 2023 $ 196,958 $ 19 3,592,722 (6,450) (3,389,333)
Beginning balance (in shares) at Mar. 31, 2023   189,235      
Beginning balance at Mar. 31, 2023 240,865 $ 19 3,584,738 (5,681) (3,338,211)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Shares issued under equity compensation plans (in shares)   884      
Shares issued under equity compensation plans 18   18    
Stock-based compensation 7,966   7,966    
Comprehensive income (loss) $ (51,891)     (769) (51,122)
Ending balance (in shares) at Jun. 30, 2023 190,119 190,119      
Ending balance at Jun. 30, 2023 $ 196,958 $ 19 $ 3,592,722 $ (6,450) $ (3,389,333)